Literature DB >> 8494878

Quantitation of pre beta-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid.

M Kawano1, T Miida, C J Fielding, P E Fielding.   

Abstract

Both receptor-mediated and diffusional processes have been proposed as mechanisms for the efflux of cellular cholesterol to plasma. The depletion of a minor high-density lipoprotein subfraction (pre beta-1-HDL) from plasma by incubation was associated with a proportional reduction in up to 58% of cholesterol and lecithin efflux from cultured fibroblasts. Pre beta-HDL-dependent efflux was blocked by protease pretreatment of the cells, while residual ("nonspecific") efflux was protease-insensitive. The whole of cholesterol efflux from blood erythrocytes was both pre beta-1-HDL-and protease-independent. These data suggest that two distinct pathways contribute to total efflux from fibroblast monolayers; one of these is directly proportional to plasma pre beta-1-HDL concentration and may involve a cell-surface protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494878     DOI: 10.1021/bi00070a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers.

Authors:  C J Fielding; A Bist; P E Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

2.  Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport.

Authors:  Takashi Kuwano; Xin Bi; Eleonora Cipollari; Tomoyuki Yasuda; William R Lagor; Hannah J Szapary; Junichiro Tohyama; John S Millar; Jeffrey T Billheimer; Nicholas N Lyssenko; Daniel J Rader
Journal:  J Lipid Res       Date:  2017-01-30       Impact factor: 5.922

3.  Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.

Authors:  L W Castellani; M Navab; B J Van Lenten; C C Hedrick; S Y Hama; A M Goto; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

4.  Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma.

Authors:  Y Huang; A von Eckardstein; S Wu; G Assmann
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

5.  The role of apolipoprotein AI domains in lipid binding.

Authors:  W S Davidson; T Hazlett; W W Mantulin; A Jonas
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

6.  Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma.

Authors:  Y Zhu; S Bellosta; C Langer; F Bernini; R E Pitas; R W Mahley; G Assmann; A von Eckardstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

7.  Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.

Authors:  L Lindstedt; M Lee; G R Castro; J C Fruchart; P T Kovanen
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

8.  Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma.

Authors:  Osamu Miyazaki; Jun Ogihara; Isamu Fukamachi; Takafumi Kasumi
Journal:  J Lipid Res       Date:  2013-12-04       Impact factor: 5.922

9.  Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.

Authors:  Anouar Hafiane; John K Bielicki; Jan O Johansson; Jacques Genest
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

10.  Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys.

Authors:  Mathieu R Brodeur; David Rhainds; Daniel Charpentier; Teodora Mihalache-Avram; Mélanie Mecteau; Geneviève Brand; Evelyne Chaput; Anne Perez; Eric J Niesor; Eric Rhéaume; Cyrille Maugeais; Jean-Claude Tardif
Journal:  J Lipid Res       Date:  2017-05-17       Impact factor: 5.922

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.